Delivery Order SPE2DE21D7020-SPE2D625F2JDG
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a major global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $32,850 by the Defense Health Agency's Medical Supply Chain under contract 4569047952. This fixed-price delivery order with economic price adjustment terms carries an ultimate completion date of August 18, 2025, and was issued on August 11, 2025. The contract is not set-aside and represents Boston Scientific's continued role as a prime...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $75,560 by the Defense Health Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 10, 2025. This fixed-price contract with economic price adjustment provisions represents a non-competitive award with no small business set-aside. As the place of performance is Boston Scientific's headquarters location in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $13,027.08 by the Defense Health Agency's Medical Supply Chain on August 4, 2025. The contract, which utilizes fixed-price pricing with economic price adjustment, is scheduled for completion by August 11, 2025. The award represents a non-set-aside competitive procurement, and the place of performance is Boston Scientific's facility in Marlborough, MA. As...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $4,505.50 by the Defense Health Agency's Medical Supply Chain on August 5, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 12, 2025 and involves performance at Boston Scientific's facility in Marlborough, MA. The award was made without a set-aside designation, allowing the company...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $8,795.18 by the Defense Health Agency's Medical Supply Chain on June 24, 2025. The contract employs fixed-price pricing with economic price adjustment terms and is scheduled for completion by July 1, 2025. The award is not set-aside and represents Boston Scientific's continued role as a prime contractor supplying advanced medical devices to federal...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $3,888.18 by the Defense Health Agency's Medical Supply Chain on August 29, 2025. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of September 8, 2025, and represents a continuation of Boston Scientific's significant role as a federal contractor supplying advanced medical devices to defense...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,593.05 by the Defense Health Agency's Medical Supply Chain on August 28, 2025. This fixed-price contract with economic price adjustment provisions is scheduled for completion by September 5, 2025, and will be performed at Boston Scientific's facility in Marlborough, MA. The award represents a continuation of Boston Scientific's role as a critical...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a fixed-price delivery order valued at $12,317.30 by the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as a non-set-aside contract with an ultimate completion date of August 27, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. The contract is...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F2JDGDelivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies advanced medical technologies including cardiovascular devices, interventional equipment, neurostimulation systems, stents, catheters, and diagnostic tools to federal healthcare agencies. This award carries no set-aside designation, indicating the company competed openly in the federal marketplace. The place of performance is Boston Scientific's Marlborough, Massachusetts facility. This delivery order falls under Boston Scientific's broader federal contracting relationship with the Defense Health Agency, which has awarded the company multiple contracts and indefinite delivery vehicles for medical device supply and support services. The company maintains a significant single-award Blanket Purchase Agreement with the DHA valued at $750,000 through March 30, 2030, positioning Boston Scientific as a critical supplier of radiation treatment devices and other specialized medical technologies to the federal defense healthcare system. The company's robust federal portfolio demonstrates its comprehensive capability to rapidly respond to evolving medical equipment requirements across Department of Veterans Affairs networks and Defense Health Agency entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/2/25 |